Review





Similar Products

90
Thermo Fisher liquid chromatography-tandem mass-spectrometry (lc-ms/ms
Liquid Chromatography Tandem Mass Spectrometry (Lc Ms/Ms, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ms/nct06380387-31-10-23
Average 90 stars, based on 1 article reviews
liquid chromatography-tandem mass-spectrometry (lc-ms/ms - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

99
YMC America liquid chromatography mass spectrometry lc ms
Reaction schemes <t>and</t> <t>LC-MS</t> analysis of Pp UGTs reactions with diosgenin and pennogenin . ( a ) Biosynthesis of trillin mediated by UGT91BP2 and UGT703R1–3 through transferring glucose from UDP-glucose to the C-3 OH position of diosgenin. ( b ) Extracted ion chromatograms (EICs) of the in vitro enzyme activity assays of recombinant UGT91BP2 and UGT703R1–3 with UDP-glucose and diosgenin showing the formation of trillin, as compared to the authentic trillin standard. Control is the empty expression vector. ( c ) MS spectra of the enzymatic reaction products in hydrogen and sodium ion adducts compared to the fragmentation pattern of the trillin standard. The product molecular ions [M + H] + and [M +Na] + and the feature fragment ion [M + H − Glc] + with m / z 415.32 are marked. Of note, additional peaks observed in the diosgenin EIC ( m / z 415.32) for UGT703R1–3 might correspond to substrate isomeric impurities, in-source adducts, or minor non-enzymatic by-products; these peaks, which arose from the extracted ion flow of the substrate m / z , did not co-elute with the product, trillin , and therefore did not affect the interpretation of the product formation. ( d ) Biosynthesis of pennogenin 3- O -glucoside mediated by the UGT703R1–3 through transferring glucose from UDP-glucose to the C-3 OH position of pennogenin. ( e ) EICs of the in vitro enzyme activity assays of recombinant UGT91BP2 and UGT703R1–3 with UDP-glucose and pennogenin showing the formation of pennogenin 3- O -glucoside, compared to the control empty expression vector. ( f ) MS/MS spectra ([M + H – Glc] + and [M + H – Glc − H 2 O] + ) of the enzymatic reaction products.
Liquid Chromatography Mass Spectrometry Lc Ms, supplied by YMC America, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ms/YMC-Triart+C18/pmc13123502-92-0-8
Average 99 stars, based on 1 article reviews
liquid chromatography mass spectrometry lc ms - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

90
IONICON Inc compact ptr-ms
Reaction schemes <t>and</t> <t>LC-MS</t> analysis of Pp UGTs reactions with diosgenin and pennogenin . ( a ) Biosynthesis of trillin mediated by UGT91BP2 and UGT703R1–3 through transferring glucose from UDP-glucose to the C-3 OH position of diosgenin. ( b ) Extracted ion chromatograms (EICs) of the in vitro enzyme activity assays of recombinant UGT91BP2 and UGT703R1–3 with UDP-glucose and diosgenin showing the formation of trillin, as compared to the authentic trillin standard. Control is the empty expression vector. ( c ) MS spectra of the enzymatic reaction products in hydrogen and sodium ion adducts compared to the fragmentation pattern of the trillin standard. The product molecular ions [M + H] + and [M +Na] + and the feature fragment ion [M + H − Glc] + with m / z 415.32 are marked. Of note, additional peaks observed in the diosgenin EIC ( m / z 415.32) for UGT703R1–3 might correspond to substrate isomeric impurities, in-source adducts, or minor non-enzymatic by-products; these peaks, which arose from the extracted ion flow of the substrate m / z , did not co-elute with the product, trillin , and therefore did not affect the interpretation of the product formation. ( d ) Biosynthesis of pennogenin 3- O -glucoside mediated by the UGT703R1–3 through transferring glucose from UDP-glucose to the C-3 OH position of pennogenin. ( e ) EICs of the in vitro enzyme activity assays of recombinant UGT91BP2 and UGT703R1–3 with UDP-glucose and pennogenin showing the formation of pennogenin 3- O -glucoside, compared to the control empty expression vector. ( f ) MS/MS spectra ([M + H – Glc] + and [M + H – Glc − H 2 O] + ) of the enzymatic reaction products.
Compact Ptr Ms, supplied by IONICON Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ms/compact+ptr+ms/nct05727852-2-9-15
Average 90 stars, based on 1 article reviews
compact ptr-ms - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

95
Agilent technologies lc ms
Reaction schemes <t>and</t> <t>LC-MS</t> analysis of Pp UGTs reactions with diosgenin and pennogenin . ( a ) Biosynthesis of trillin mediated by UGT91BP2 and UGT703R1–3 through transferring glucose from UDP-glucose to the C-3 OH position of diosgenin. ( b ) Extracted ion chromatograms (EICs) of the in vitro enzyme activity assays of recombinant UGT91BP2 and UGT703R1–3 with UDP-glucose and diosgenin showing the formation of trillin, as compared to the authentic trillin standard. Control is the empty expression vector. ( c ) MS spectra of the enzymatic reaction products in hydrogen and sodium ion adducts compared to the fragmentation pattern of the trillin standard. The product molecular ions [M + H] + and [M +Na] + and the feature fragment ion [M + H − Glc] + with m / z 415.32 are marked. Of note, additional peaks observed in the diosgenin EIC ( m / z 415.32) for UGT703R1–3 might correspond to substrate isomeric impurities, in-source adducts, or minor non-enzymatic by-products; these peaks, which arose from the extracted ion flow of the substrate m / z , did not co-elute with the product, trillin , and therefore did not affect the interpretation of the product formation. ( d ) Biosynthesis of pennogenin 3- O -glucoside mediated by the UGT703R1–3 through transferring glucose from UDP-glucose to the C-3 OH position of pennogenin. ( e ) EICs of the in vitro enzyme activity assays of recombinant UGT91BP2 and UGT703R1–3 with UDP-glucose and pennogenin showing the formation of pennogenin 3- O -glucoside, compared to the control empty expression vector. ( f ) MS/MS spectra ([M + H – Glc] + and [M + H – Glc − H 2 O] + ) of the enzymatic reaction products.
Lc Ms, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ms/Bio+LC/pmc13749058-213-5-8
Average 95 stars, based on 1 article reviews
lc ms - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

95
Agilent technologies liquid chromatography ms
Reaction schemes <t>and</t> <t>LC-MS</t> analysis of Pp UGTs reactions with diosgenin and pennogenin . ( a ) Biosynthesis of trillin mediated by UGT91BP2 and UGT703R1–3 through transferring glucose from UDP-glucose to the C-3 OH position of diosgenin. ( b ) Extracted ion chromatograms (EICs) of the in vitro enzyme activity assays of recombinant UGT91BP2 and UGT703R1–3 with UDP-glucose and diosgenin showing the formation of trillin, as compared to the authentic trillin standard. Control is the empty expression vector. ( c ) MS spectra of the enzymatic reaction products in hydrogen and sodium ion adducts compared to the fragmentation pattern of the trillin standard. The product molecular ions [M + H] + and [M +Na] + and the feature fragment ion [M + H − Glc] + with m / z 415.32 are marked. Of note, additional peaks observed in the diosgenin EIC ( m / z 415.32) for UGT703R1–3 might correspond to substrate isomeric impurities, in-source adducts, or minor non-enzymatic by-products; these peaks, which arose from the extracted ion flow of the substrate m / z , did not co-elute with the product, trillin , and therefore did not affect the interpretation of the product formation. ( d ) Biosynthesis of pennogenin 3- O -glucoside mediated by the UGT703R1–3 through transferring glucose from UDP-glucose to the C-3 OH position of pennogenin. ( e ) EICs of the in vitro enzyme activity assays of recombinant UGT91BP2 and UGT703R1–3 with UDP-glucose and pennogenin showing the formation of pennogenin 3- O -glucoside, compared to the control empty expression vector. ( f ) MS/MS spectra ([M + H – Glc] + and [M + H – Glc − H 2 O] + ) of the enzymatic reaction products.
Liquid Chromatography Ms, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ms/Bio+LC/pm42971099-80-6-10
Average 95 stars, based on 1 article reviews
liquid chromatography ms - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

95
Agilent technologies lc ms analyses
Reaction schemes <t>and</t> <t>LC-MS</t> analysis of Pp UGTs reactions with diosgenin and pennogenin . ( a ) Biosynthesis of trillin mediated by UGT91BP2 and UGT703R1–3 through transferring glucose from UDP-glucose to the C-3 OH position of diosgenin. ( b ) Extracted ion chromatograms (EICs) of the in vitro enzyme activity assays of recombinant UGT91BP2 and UGT703R1–3 with UDP-glucose and diosgenin showing the formation of trillin, as compared to the authentic trillin standard. Control is the empty expression vector. ( c ) MS spectra of the enzymatic reaction products in hydrogen and sodium ion adducts compared to the fragmentation pattern of the trillin standard. The product molecular ions [M + H] + and [M +Na] + and the feature fragment ion [M + H − Glc] + with m / z 415.32 are marked. Of note, additional peaks observed in the diosgenin EIC ( m / z 415.32) for UGT703R1–3 might correspond to substrate isomeric impurities, in-source adducts, or minor non-enzymatic by-products; these peaks, which arose from the extracted ion flow of the substrate m / z , did not co-elute with the product, trillin , and therefore did not affect the interpretation of the product formation. ( d ) Biosynthesis of pennogenin 3- O -glucoside mediated by the UGT703R1–3 through transferring glucose from UDP-glucose to the C-3 OH position of pennogenin. ( e ) EICs of the in vitro enzyme activity assays of recombinant UGT91BP2 and UGT703R1–3 with UDP-glucose and pennogenin showing the formation of pennogenin 3- O -glucoside, compared to the control empty expression vector. ( f ) MS/MS spectra ([M + H – Glc] + and [M + H – Glc − H 2 O] + ) of the enzymatic reaction products.
Lc Ms Analyses, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ms/Bio+LC/pmc13744403-99-1-4
Average 95 stars, based on 1 article reviews
lc ms analyses - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

96
Danaher Inc triple quad 3500
Reaction schemes <t>and</t> <t>LC-MS</t> analysis of Pp UGTs reactions with diosgenin and pennogenin . ( a ) Biosynthesis of trillin mediated by UGT91BP2 and UGT703R1–3 through transferring glucose from UDP-glucose to the C-3 OH position of diosgenin. ( b ) Extracted ion chromatograms (EICs) of the in vitro enzyme activity assays of recombinant UGT91BP2 and UGT703R1–3 with UDP-glucose and diosgenin showing the formation of trillin, as compared to the authentic trillin standard. Control is the empty expression vector. ( c ) MS spectra of the enzymatic reaction products in hydrogen and sodium ion adducts compared to the fragmentation pattern of the trillin standard. The product molecular ions [M + H] + and [M +Na] + and the feature fragment ion [M + H − Glc] + with m / z 415.32 are marked. Of note, additional peaks observed in the diosgenin EIC ( m / z 415.32) for UGT703R1–3 might correspond to substrate isomeric impurities, in-source adducts, or minor non-enzymatic by-products; these peaks, which arose from the extracted ion flow of the substrate m / z , did not co-elute with the product, trillin , and therefore did not affect the interpretation of the product formation. ( d ) Biosynthesis of pennogenin 3- O -glucoside mediated by the UGT703R1–3 through transferring glucose from UDP-glucose to the C-3 OH position of pennogenin. ( e ) EICs of the in vitro enzyme activity assays of recombinant UGT91BP2 and UGT703R1–3 with UDP-glucose and pennogenin showing the formation of pennogenin 3- O -glucoside, compared to the control empty expression vector. ( f ) MS/MS spectra ([M + H – Glc] + and [M + H – Glc − H 2 O] + ) of the enzymatic reaction products.
Triple Quad 3500, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ms/SCIEX+Triple+Quad+3500+LC-MS%2FMS+System/pm42982162-113-8-6
Average 96 stars, based on 1 article reviews
triple quad 3500 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
IKA-Works inc magnetic stirrer
Reaction schemes <t>and</t> <t>LC-MS</t> analysis of Pp UGTs reactions with diosgenin and pennogenin . ( a ) Biosynthesis of trillin mediated by UGT91BP2 and UGT703R1–3 through transferring glucose from UDP-glucose to the C-3 OH position of diosgenin. ( b ) Extracted ion chromatograms (EICs) of the in vitro enzyme activity assays of recombinant UGT91BP2 and UGT703R1–3 with UDP-glucose and diosgenin showing the formation of trillin, as compared to the authentic trillin standard. Control is the empty expression vector. ( c ) MS spectra of the enzymatic reaction products in hydrogen and sodium ion adducts compared to the fragmentation pattern of the trillin standard. The product molecular ions [M + H] + and [M +Na] + and the feature fragment ion [M + H − Glc] + with m / z 415.32 are marked. Of note, additional peaks observed in the diosgenin EIC ( m / z 415.32) for UGT703R1–3 might correspond to substrate isomeric impurities, in-source adducts, or minor non-enzymatic by-products; these peaks, which arose from the extracted ion flow of the substrate m / z , did not co-elute with the product, trillin , and therefore did not affect the interpretation of the product formation. ( d ) Biosynthesis of pennogenin 3- O -glucoside mediated by the UGT703R1–3 through transferring glucose from UDP-glucose to the C-3 OH position of pennogenin. ( e ) EICs of the in vitro enzyme activity assays of recombinant UGT91BP2 and UGT703R1–3 with UDP-glucose and pennogenin showing the formation of pennogenin 3- O -glucoside, compared to the control empty expression vector. ( f ) MS/MS spectra ([M + H – Glc] + and [M + H – Glc − H 2 O] + ) of the enzymatic reaction products.
Magnetic Stirrer, supplied by IKA-Works inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ms/IKA+C-MAG+MS+10+Magnetic+Stirrer/10__1007_slash_s41981___026___00385___4-72-38-40
Average 96 stars, based on 1 article reviews
magnetic stirrer - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

99
Danaher Inc qtrap 6500 lc ms ms system
Reaction schemes <t>and</t> <t>LC-MS</t> analysis of Pp UGTs reactions with diosgenin and pennogenin . ( a ) Biosynthesis of trillin mediated by UGT91BP2 and UGT703R1–3 through transferring glucose from UDP-glucose to the C-3 OH position of diosgenin. ( b ) Extracted ion chromatograms (EICs) of the in vitro enzyme activity assays of recombinant UGT91BP2 and UGT703R1–3 with UDP-glucose and diosgenin showing the formation of trillin, as compared to the authentic trillin standard. Control is the empty expression vector. ( c ) MS spectra of the enzymatic reaction products in hydrogen and sodium ion adducts compared to the fragmentation pattern of the trillin standard. The product molecular ions [M + H] + and [M +Na] + and the feature fragment ion [M + H − Glc] + with m / z 415.32 are marked. Of note, additional peaks observed in the diosgenin EIC ( m / z 415.32) for UGT703R1–3 might correspond to substrate isomeric impurities, in-source adducts, or minor non-enzymatic by-products; these peaks, which arose from the extracted ion flow of the substrate m / z , did not co-elute with the product, trillin , and therefore did not affect the interpretation of the product formation. ( d ) Biosynthesis of pennogenin 3- O -glucoside mediated by the UGT703R1–3 through transferring glucose from UDP-glucose to the C-3 OH position of pennogenin. ( e ) EICs of the in vitro enzyme activity assays of recombinant UGT91BP2 and UGT703R1–3 with UDP-glucose and pennogenin showing the formation of pennogenin 3- O -glucoside, compared to the control empty expression vector. ( f ) MS/MS spectra ([M + H – Glc] + and [M + H – Glc − H 2 O] + ) of the enzymatic reaction products.
Qtrap 6500 Lc Ms Ms System, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ms/QTRAP+6500%2B+System/pm42977911-102-16-14
Average 99 stars, based on 1 article reviews
qtrap 6500 lc ms ms system - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

95
Proteintech ms acetylated tubulin
A . Representative images of cilia from Ad-Scr and Ad-Tulp3 KD islets. B . Quantification of 5-HT6 ciliary intensity normalized to <t>acetylated</t> <t>tubulin</t> intensity. n =20 Ad-Scr, 37 Ad-Tulp3 cilia. 5-HT6 ciliary expression is significantly decreased after Tulp3 KD. C . Quantification of whole-islet 5-HT6 expression. Tulp3 KD does not alter whole-islet expression of 5-HT6. n =23 Ad-Scr, 26 Ad-Tulp3 islets. D . Quantification of AcTUB intensity showing no difference between groups. n =21 Ad-Scr, 25 Ad-Tulp3 cilia. E . Scramble-treated controls (Ad-Scr) or Tulp3 KD (Ad-Tulp3) islets were infected with a beta-cell-specific cAMP sensor and treated with 5-HT6 agonist WAY-208466 (WAY). Tulp3 KD significantly attenuated the cAMP response to WAY, as measured by area under the curve (AUC). n =47 Ad-Scr, 42 Ad-Tulp3 islets. F . The cAMP response to positive control forskolin is comparable between Ad-Scr and Ad-Tulp3 islets as measured by AUC. G . Ad-Scr and Ad-Tulp3 islets were subjected to glucose-stimulated insulin secretion (GSIS) assay with 5-HT6 stimulation. Ad-Tulp3 islets fail to augment insulin secretion in response to 5-HT6 agonism. n =4 biological replicates. H . Male wild-type islets treated with PKI constructs were subjected to GSIS assay with 5-HT6 stimulation. Loss of ciliary PKA signaling attenuated the insulin secretory response to 5-HT6 agonism. n =3 biological replicates. * p< 0.05, * * p <0.01, *** p <0.001, **** p <0.0001, ns = not significant. Scale: 2 µm.
Ms Acetylated Tubulin, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ms/acetylated+Tubulin(Lys40)+Antibody/bio_rxiv__64898__2026__10__30__763155-37-6-9
Average 95 stars, based on 1 article reviews
ms acetylated tubulin - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

Image Search Results


Reaction schemes and LC-MS analysis of Pp UGTs reactions with diosgenin and pennogenin . ( a ) Biosynthesis of trillin mediated by UGT91BP2 and UGT703R1–3 through transferring glucose from UDP-glucose to the C-3 OH position of diosgenin. ( b ) Extracted ion chromatograms (EICs) of the in vitro enzyme activity assays of recombinant UGT91BP2 and UGT703R1–3 with UDP-glucose and diosgenin showing the formation of trillin, as compared to the authentic trillin standard. Control is the empty expression vector. ( c ) MS spectra of the enzymatic reaction products in hydrogen and sodium ion adducts compared to the fragmentation pattern of the trillin standard. The product molecular ions [M + H] + and [M +Na] + and the feature fragment ion [M + H − Glc] + with m / z 415.32 are marked. Of note, additional peaks observed in the diosgenin EIC ( m / z 415.32) for UGT703R1–3 might correspond to substrate isomeric impurities, in-source adducts, or minor non-enzymatic by-products; these peaks, which arose from the extracted ion flow of the substrate m / z , did not co-elute with the product, trillin , and therefore did not affect the interpretation of the product formation. ( d ) Biosynthesis of pennogenin 3- O -glucoside mediated by the UGT703R1–3 through transferring glucose from UDP-glucose to the C-3 OH position of pennogenin. ( e ) EICs of the in vitro enzyme activity assays of recombinant UGT91BP2 and UGT703R1–3 with UDP-glucose and pennogenin showing the formation of pennogenin 3- O -glucoside, compared to the control empty expression vector. ( f ) MS/MS spectra ([M + H – Glc] + and [M + H – Glc − H 2 O] + ) of the enzymatic reaction products.

Journal: Synthetic and Systems Biotechnology

Article Title: Functional characterization of four glycosyltransferases for biosynthesis of steroidal saponins in medicinal plant Paris polyphylla

doi: 10.1016/j.synbio.2026.04.002

Figure Lengend Snippet: Reaction schemes and LC-MS analysis of Pp UGTs reactions with diosgenin and pennogenin . ( a ) Biosynthesis of trillin mediated by UGT91BP2 and UGT703R1–3 through transferring glucose from UDP-glucose to the C-3 OH position of diosgenin. ( b ) Extracted ion chromatograms (EICs) of the in vitro enzyme activity assays of recombinant UGT91BP2 and UGT703R1–3 with UDP-glucose and diosgenin showing the formation of trillin, as compared to the authentic trillin standard. Control is the empty expression vector. ( c ) MS spectra of the enzymatic reaction products in hydrogen and sodium ion adducts compared to the fragmentation pattern of the trillin standard. The product molecular ions [M + H] + and [M +Na] + and the feature fragment ion [M + H − Glc] + with m / z 415.32 are marked. Of note, additional peaks observed in the diosgenin EIC ( m / z 415.32) for UGT703R1–3 might correspond to substrate isomeric impurities, in-source adducts, or minor non-enzymatic by-products; these peaks, which arose from the extracted ion flow of the substrate m / z , did not co-elute with the product, trillin , and therefore did not affect the interpretation of the product formation. ( d ) Biosynthesis of pennogenin 3- O -glucoside mediated by the UGT703R1–3 through transferring glucose from UDP-glucose to the C-3 OH position of pennogenin. ( e ) EICs of the in vitro enzyme activity assays of recombinant UGT91BP2 and UGT703R1–3 with UDP-glucose and pennogenin showing the formation of pennogenin 3- O -glucoside, compared to the control empty expression vector. ( f ) MS/MS spectra ([M + H – Glc] + and [M + H – Glc − H 2 O] + ) of the enzymatic reaction products.

Article Snippet: Liquid chromatography-mass spectrometry (LC-MS) was equipped with a YMC-Triart C18 column (250 mm × 4.6 mm, 5 μm), and the column temperature was set to 30 °C.

Techniques: Liquid Chromatography with Mass Spectroscopy, Transferring, In Vitro, Activity Assay, Recombinant, Control, Expressing, Plasmid Preparation, Tandem Mass Spectroscopy

A . Representative images of cilia from Ad-Scr and Ad-Tulp3 KD islets. B . Quantification of 5-HT6 ciliary intensity normalized to acetylated tubulin intensity. n =20 Ad-Scr, 37 Ad-Tulp3 cilia. 5-HT6 ciliary expression is significantly decreased after Tulp3 KD. C . Quantification of whole-islet 5-HT6 expression. Tulp3 KD does not alter whole-islet expression of 5-HT6. n =23 Ad-Scr, 26 Ad-Tulp3 islets. D . Quantification of AcTUB intensity showing no difference between groups. n =21 Ad-Scr, 25 Ad-Tulp3 cilia. E . Scramble-treated controls (Ad-Scr) or Tulp3 KD (Ad-Tulp3) islets were infected with a beta-cell-specific cAMP sensor and treated with 5-HT6 agonist WAY-208466 (WAY). Tulp3 KD significantly attenuated the cAMP response to WAY, as measured by area under the curve (AUC). n =47 Ad-Scr, 42 Ad-Tulp3 islets. F . The cAMP response to positive control forskolin is comparable between Ad-Scr and Ad-Tulp3 islets as measured by AUC. G . Ad-Scr and Ad-Tulp3 islets were subjected to glucose-stimulated insulin secretion (GSIS) assay with 5-HT6 stimulation. Ad-Tulp3 islets fail to augment insulin secretion in response to 5-HT6 agonism. n =4 biological replicates. H . Male wild-type islets treated with PKI constructs were subjected to GSIS assay with 5-HT6 stimulation. Loss of ciliary PKA signaling attenuated the insulin secretory response to 5-HT6 agonism. n =3 biological replicates. * p< 0.05, * * p <0.01, *** p <0.001, **** p <0.0001, ns = not significant. Scale: 2 µm.

Journal: bioRxiv

Article Title: Serotonin signals through ciliary 5-HT6 to control insulin secretion

doi: 10.64898/2026.10.30.763155

Figure Lengend Snippet: A . Representative images of cilia from Ad-Scr and Ad-Tulp3 KD islets. B . Quantification of 5-HT6 ciliary intensity normalized to acetylated tubulin intensity. n =20 Ad-Scr, 37 Ad-Tulp3 cilia. 5-HT6 ciliary expression is significantly decreased after Tulp3 KD. C . Quantification of whole-islet 5-HT6 expression. Tulp3 KD does not alter whole-islet expression of 5-HT6. n =23 Ad-Scr, 26 Ad-Tulp3 islets. D . Quantification of AcTUB intensity showing no difference between groups. n =21 Ad-Scr, 25 Ad-Tulp3 cilia. E . Scramble-treated controls (Ad-Scr) or Tulp3 KD (Ad-Tulp3) islets were infected with a beta-cell-specific cAMP sensor and treated with 5-HT6 agonist WAY-208466 (WAY). Tulp3 KD significantly attenuated the cAMP response to WAY, as measured by area under the curve (AUC). n =47 Ad-Scr, 42 Ad-Tulp3 islets. F . The cAMP response to positive control forskolin is comparable between Ad-Scr and Ad-Tulp3 islets as measured by AUC. G . Ad-Scr and Ad-Tulp3 islets were subjected to glucose-stimulated insulin secretion (GSIS) assay with 5-HT6 stimulation. Ad-Tulp3 islets fail to augment insulin secretion in response to 5-HT6 agonism. n =4 biological replicates. H . Male wild-type islets treated with PKI constructs were subjected to GSIS assay with 5-HT6 stimulation. Loss of ciliary PKA signaling attenuated the insulin secretory response to 5-HT6 agonism. n =3 biological replicates. * p< 0.05, * * p <0.01, *** p <0.001, **** p <0.0001, ns = not significant. Scale: 2 µm.

Article Snippet: Antibodies and dilutions used were 1:400 ms acetylated tubulin (Proteintech), 1:400 gp ARL13b (Proteintech), 1:400 rb 5-HT6 (Proteintech), 1:400 ms insulin (Proteintech), 1:3 gp insulin (Agilent), 1:1000 ms glucagon (Abcam).

Techniques: Expressing, Infection, Positive Control, Construct